Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Parr

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Pain Physician|April 26, 2013
Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapyLaxmaiah Manchikanti, Frank J E Falco, Ramsin M Benyamin, et al.
Scientific Reports|June 29, 2016
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growthD M Brown, H Williams, K J P Ryan, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Pain Physician|August 1, 2009
Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal painLaxmaiah Manchikanti, Mark V Boswell, Vijay Singh, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Journal of Medicinal Chemistry|December 12, 2024
Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using an <i>In Silico</i> Enabled Drug Discovery PlatformHideyuki Igawa, Zef A Konst, Eric Therrien, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)Mingshuo Zeng, Jessica M Grandner, Marian C Bryan, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase InhibitorsBrendan T Parr, Richard Pastor, Benjamin D Sellers, et al.
Journal of Medicinal Chemistry|June 22, 2026
Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 InhibitorsVishal A Verma, Jessica M Grandner, Brendan T Parr, et al.
Pain Physician|April 26, 2013
An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendationsLaxmaiah Manchikanti, Salahadin Abdi, Sairam Atluri, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Pain Physician|April 26, 2013
Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapyLaxmaiah Manchikanti, Frank J E Falco, Ramsin M Benyamin, et al.
Scientific Reports|June 29, 2016
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growthD M Brown, H Williams, K J P Ryan, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Pain Physician|August 1, 2009
Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal painLaxmaiah Manchikanti, Mark V Boswell, Vijay Singh, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Journal of Medicinal Chemistry|December 12, 2024
Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using an <i>In Silico</i> Enabled Drug Discovery PlatformHideyuki Igawa, Zef A Konst, Eric Therrien, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)Mingshuo Zeng, Jessica M Grandner, Marian C Bryan, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase InhibitorsBrendan T Parr, Richard Pastor, Benjamin D Sellers, et al.
Journal of Medicinal Chemistry|June 22, 2026
Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 InhibitorsVishal A Verma, Jessica M Grandner, Brendan T Parr, et al.
Pain Physician|April 26, 2013
An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendationsLaxmaiah Manchikanti, Salahadin Abdi, Sairam Atluri, et al.
Pageof 8